The pollen enigma: Modulation of the allergic immune response by non-allergenic, pollen-derived compounds

Current Pharmaceutical Design

Volumn 18, Issue 16, 2012, Pages 2314-2319

  Gilles, Stefanie ^a   Behrendt, Heidrun ^a   Ring, Johannes ^a   Traidl Hoffmann, Claudia ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adjuvant factors; Allergy; Metabolome; PALMs; Pollen

Indexed keywords

POLLEN ANTIGEN;

ALLERGENICITY; GENETIC PREDISPOSITION; IMMUNE RESPONSE; IMMUNOMODULATION; POLLEN ALLERGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHEMOTAXIS; HUMANS; HYPERSENSITIVITY; OXIDATIVE STRESS; PEPTIDE HYDROLASES; POLLEN; SYSTEMS BIOLOGY;

EID: 84860190695     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212800166040     Document Type: Review

References (80)

1. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. The European respiratory journal: official J Eur Society for Clinical Respiratory Physiol 2004; 24(5): 758-764.
2. Coca AF. The Skin as a Shock Tissue. Bulletin of the New York Academy of Medicine 1929; 5(3): 223-231.
3. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol 1966; 97(6): 840-853.
4. Calderon MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J allergy clinical Immunol 2011; 127(1): 30-38.
5. Lockey RF, Hankin CS. Health economics of allergen-specific immunotherapy in the United States. J allergy clinical Immunol 2011; 127(1): 39-43.
6. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J allergy and clinical Immunol 2011; 127(1): 18-27; quiz 8-9.
7. Traidl-Hoffmann C, Jakob T, Behrendt H. Determinants of allergenicity. J Allergy Clin Immunol 2009; 123: 558-566.
8. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004; 4(12): 978-988.
9. Kabesch M, Schedel M, Carr D, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. The J allergy and clinical Immunol 2006; 117(2): 269-274.
10. Weidinger S, Gieger C, Rodriguez E, et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS genetics 2008; 4(8): e1000166.
11. Lara-Marquez ML, Yunis JJ, Layrisse Z, et al. Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population. Clin Exp Allergy 1999; 29(1): 60-71.
12. Yang IA, Fong KM, Holgate ST, Holloway JW. The role of Tolllike receptors and related receptors of the innate immune system in asthma. Current opinion allergy clinical Immunol 2006; 6(1): 23-28.
13. Weidinger S, O'Sullivan M, Illig T, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. The J allergy and clinical Immunol 2008; 121(5): 1203-1209+e1.
14. Tesse R, Pandey RC, Kabesch M. Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy 2011; 66(3): 307-316.
15. Eder W, Klimecki W, Yu L, et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. The J allergy and clinical Immunol 2004; 113(3): 482-488.
16. Brand S, Teich R, Dicke T, et al. Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes. The J allergy and clinical Immunol 2011.
17. Buters JT, Kasche A, Weichenmeier I, et al. Year-to-year variation in release of Bet v 1 allergen from birch pollen: evidence for geographical differences between West and South Germany. International archives of allergy and Immunol 2008; 145(2): 122-130.
18. Buters JT, Weichenmeier I, Ochs S, et al. The allergen Bet v 1 in fractions of ambient air deviates from birch pollen counts. Allergy 2010; 65(7): 850-858.
19. Blaser K. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production. Advances in experimental medicine and biology 1996; 409: 295-303.
20. Flicker S, Steinberger P, Ball T, et al. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. The J allergy and clinical Immunol 2006; 117(6): 1336-1343.
21. Vrtala S, Fohr M, Campana R, Baumgartner C, Valent P, Valenta R. Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination. Vaccine 2011; 29(11): 2140-2148.
22. Aalberse RC. Structural biology of allergens. The J allergy and clinical Immunol 2000; 106(2): 228-238.
23. Furmonaviciene R, Sutton BJ, Glaser F, et al. An attempt to define allergen-specific molecular surface features: a bioinformatics approach. Bioinformatics 2005; 21(23): 4201-4204.
24. Radauer C, Breiteneder H. Pollen allergens are restricted to few protein families and show distinct patterns of species distribution. The J allergy and clinical Immunol 2006; 117(1): 141-147.
25. Radauer C, Bublin M, Wagner S, Mari A, Breiteneder H. Allergens are distributed into few protein families and possess a restricted number of biochemical functions. The J allergy and clinical Immunol 2008; 121(4): 847-852+e7.
26. Emanuelsson C, Spangfort MD. Allergens as eukaryotic proteins lacking bacterial homologues. Molecular Immunol 2007; 44(12): 3256-3260.
27. Zeller S, Glaser AG, Vilhelmsson M, Rhyner C, Crameri R. Immunoglobulin-E-mediated reactivity to self antigens: a controversial issue. International archives of allergy and Immunol 2008; 145(2): 87-93.
28. Aalberse RC, Stadler BM. In silico predictability of allergenicity: from amino acid sequence via 3-D structure to allergenicity. Molecular nutrition & food research 2006; 50(7): 625-627.
29. Gough L, Schulz O, Sewell HF, Shakib F. The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response. The J experimental medicine 1999; 190(12): 1897-1902.
30. Kikuchi Y, Takai T, Kuhara T, et al. Crucial commitment of proteolytic activity of a purified recombinant major house dust mite allergen Der p1 to sensitization toward IgE and IgG responses. J Immunol 2006; 177(3): 1609-1617.
31. Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J clinical Investigat 1999; 104(1): 123-133.
32. Deb R, Shakib F, Reid K, Clark H. Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D. J Biolog Chem 2007; 282(51): 36808-36819.
33. Shakib F, Schulz O, Sewell H. A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity. Immunol today 1998; 19(7): 313-316.
34. Furmonaviciene R, Ghaemmaghami AM, Boyd SE, et al. The protease allergen Der p 1 cleaves cell surface DC-SIGN and DCSIGNR: experimental analysis of in silico substrate identification and implications in allergic responses. Clin Exp Allergy 2007; 37(2): 231-242.
35. Mogensen JE, Ferreras M, Wimmer R, Petersen SV, Enghild JJ, Otzen DE. The major allergen from birch tree pollen, Bet v 1, binds and permeabilizes membranes. Biochemistry 2007; 46(11): 3356-3365.
36. Grobe K, Poppelmann M, Becker WM, Petersen A. Properties of group I allergens from grass pollen and their relation to cathepsin B, a member of the C1 family of cysteine proteinases. Eur J biochemistry / FEBS 2002; 269(8): 2083-2092.
37. Li LC, Cosgrove DJ. Grass group I pollen allergens (betaexpansins) lack proteinase activity and do not cause wall loosening via proteolysis. Eur J biochemistry / FEBS 2001; 268(15): 4217-4226.
38. Raftery MJ, Saldanha RG, Geczy CL, Kumar RK. Mass spectrometric analysis of electrophoretically separated allergens and proteases in grass pollen diffusates. Respiratory research 2003; 4: 10.
39. Ibrahim AR, Kawamoto S, Aki T, et al. Molecular cloning and immunochemical characterization of a novel major Japanese cedar pollen allergen belonging to the aspartic protease family. International archives of allergy and Immunol 2010; 152(3): 207-218.
40. Swoboda I, Grote M, Verdino P, et al. Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles. J Immunol 2004; 172(10): 6490-6500.
41. Taylor PE, Flagan RC, Valenta R, Glovsky MM. Release of allergens as respirable aerosols: A link between grass pollen and asthma. J allergy Clinical Immunol 2002; 109(1): 51-56.
42. Joenvaara S, Mattila P, Renkonen J, et al. Caveolar transport through nasal epithelium of birch pollen allergen Bet v 1 in allergic patients. The J allergy and clinical Immunol 2009; 124(1): 135-142+e1-21.
43. Mattila P, Renkonen J, Toppila-Salmi S, et al. Time-series nasal epithelial transcriptomics during natural pollen exposure in healthy subjects and allergic patients. Allergy 2010; 65(2): 175-183.
44. Bagarozzi DA, Jr., Pike R, Potempa J, Travis J. Purification and characterization of a novel endopeptidase in ragweed (Ambrosia artemisiifolia) pollen. The J biological chemistry 1996; 271(42): 26227-26232.
45. Bagarozzi DA, Jr., Travis J. Ragweed pollen proteolytic enzymes: possible roles in allergies and asthma. Phytochemistry 1998; 47(4): 593-598.
46. Cortes L, Carvalho AL, Todo-Bom A, Faro C, Pires E, Verissimo P. Purification of a novel aminopeptidase from the pollen of Parietaria judaica that alters epithelial integrity and degrades neuropeptides. J allergy clinical Immunol 2006; 118(4): 878-884.
47. Runswick S, Mitchell T, Davies P, Robinson C, Garrod DR. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007; 12(6): 834-842.
48. Gunawan H, Takai T, Ikeda S, Okumura K, Ogawa H. Protease activity of allergenic pollen of cedar, cypress, juniper, birch and ragweed. Allergology international: official J Japanese Society Allergology 2008; 57(1): 83-91.
49. Bacsi A, Dharajiya N, Choudhury BK, Sur S, Boldogh I. Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J allergy and clinical Immunol 2005; 116(4): 836-843.
50. Boldogh I, Bacsi A, Choudhury BK, et al. ROS generated by pollen NADPH oxidase provide a signal that augments antigeninduced allergic airway inflammation. The J clinical investigation 2005; 115(8): 2169-2179.
51. Potocky M, Jones MA, Bezvoda R, Smirnoff N, Zarsky V. Reactive oxygen species produced by NADPH oxidase are involved in pollen tube growth. The New phytologist 2007; 174(4): 742-751.
52. Kruzel ML, Bacsi A, Choudhury B, Sur S, Boldogh I. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunol 2006; 119(2): 159-166.
53. Dharajiya N, Choudhury BK, Bacsi A, Boldogh I, Alam R, Sur S. Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase-induced signal by intrapulmonary administration of antioxidants blocks allergic airway inflammation. The J allergy and clinical Immunol 2007; 119(3): 646-653.
54. Wang XL, Takai T, Kamijo S, Gunawan H, Ogawa H, Okumura K. NADPH oxidase activity in allergenic pollen grains of different plant species. Biochemical and biophysical research communications 2009; 387(3): 430-434.
55. Behrendt H, Kasche A, Ebner von Eschenbach C, Risse U, Huss- Marp J, Ring J. Secretion of proinflammatory eicosanoid-like substances precedes allergen release from pollen grains in the initiation of allergic sensitization. International archives of allergy and Immunol 2001; 124(1-3): 121-125.
56. Gunawan H, Takai T, Kamijo S, et al. Characterization of proteases, proteins, and eicosanoid-like substances in soluble extracts from allergenic pollen grains. International archives of allergy and Immunol 2008; 147(4): 276-288.
57. Thoma I, Krischke M, Loeffler C, Mueller MJ. The isoprostanoid pathway in plants. Chem Phys Lipids 2004; 128(1-2): 135-148.
58. Traidl-Hoffmann C, Mariani V, Hochrein H, et al. Pollenassociated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. The J experimental medicine 2005; 201(4): 627-636.
59. Imbusch R, Mueller MJ. Analysis of oxidative stress and woundinducible dinor isoprostanes F(1) (phytoprostanes F(1)) in plants. Plant Physiol 2000; 124(3): 1293-1304.
60. Pruitt RE, Vielle-Calzada JP, Ploense SE, Grossniklaus U, Lolle SJ. FIDDLEHEAD, a gene required to suppress epidermal cell interactions in Arabidopsis, encodes a putative lipid biosynthetic enzyme. Proceedings of the National Academy of Sciences of the United States of America 2000; 97(3): 1311-1316.
61. Traidl-Hoffmann C, Kasche A, Jakob T, et al. Lipid mediators from pollen act as chemoattractants and activators of polymorphonuclear granulocytes. The J allergy and clinical Immunol 2002; 109(5): 831-838.
62. Plotz SG, Traidl-Hoffmann C, Feussner I, et al. Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators. The J allergy and clinical Immunol 2004; 113(6): 1152-1160.
63. Gilles S, Mariani V, Bryce M, et al. Pollen-derived E1- phytoprostanes signal via PPAR-gamma and NF-kappaBdependent mechanisms. J Immunol 2009; 182(11): 6653-6658.
64. Gutermuth J, Bewersdorff M, Traidl-Hoffmann C, et al. Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo. The J allergy and clinical Immunol 2007; 120(2): 293-299.
65. Mariani V, Gilles S, Jakob T, et al. Immunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and license them for Th2 attraction. J Immunol 2007; 178(12): 7623-7631.
66. Gilles S, Jacoby D, Blume C, et al. Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses. Clin Exp Allergy 2010; 40(2): 269-278.
67. Metz M, Gilles S, Geldmacher A, Behrendt H, Traidl-Hoffmann C, Maurer M. Evidence for non-allergic mast cell activation in pollenassociated inflammation. J Invest Dermatol 2011; 131(4): 987-990.
68. Francis JN, James LK, Paraskevopoulos G, et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. The J allergy and clinical Immunol 2008; 121(5): 1120-1125+e2.
69. James LK, Shamji MH, Walker SM, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. The J allergy and clinical Immunol 2011; 127(2): 509-516+e1-5.
70. Van Overtvelt L, Wambre E, Maillere B, et al. Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol 2008; 180(7): 4514-4522.
71. Wambre E, Bonvalet M, Bodo VB, et al. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses. Clin Exp Allergy 2011; 41(2): 192-203.
72. Gilles S, Fekete A, Zhang X, et al. Pollen metabolome analysis reveals adenosine as a major regulator of dendritic cell-primed T(H) cell responses. The J allergy and clinical Immunol 2011; 127(2): 454-461+e1-9.
73. Mittag D, Scholzen A, Varese N, et al. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells. J Immunol 2010; 184(9): 4708-4716.
74. Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34(9): 1364-1372.
75. Thunberg S, Akdis M, Akdis CA, et al. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls. Clin Exp Allergy 2007; 37(8): 1127-1136.
76. Novitskiy SV, Ryzhov S, Zaynagetdinov R, et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 2008; 112(5): 1822-1831.
77. Panther E, Idzko M, Herouy Y, et al. Expression and function of adenosine receptors in human dendritic cells. Faseb J 2001; 15(11): 1963-1970.
78. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 1988; 138(5): 1143-1151.
79. Yip K, Lau H, Wise H. Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A(1) and A(2B) adenosine receptors. Br J Pharmacol 2011; 164(2b): 807-819.
80. Nunomura S, Gon Y, Yoshimaru T, Kashiwakura J, Kawakami T, Ra C. FcepsilonRI beta-chain ITAM amplifies PI3K-signaling to ensure synergistic degranulation response via FcepsilonRI and adenosine receptors. Eur J Immunol 2010; 40(4): 1205-1217.